Volastra Therapeutics News and Activities

View the org chart displaying its 21 main executives

Most searched biographies at Volastra Therapeutics

• David Southwell, Chief Executive Officer
• Jill Goldstein, Director
• Arjun Balar, Director

Popular executive movements at Volastra Therapeutics

• Scott Drutman, Chief Medical Officer and Head of Research & Development, has left the company  (posted on January 7 2026).
• Timothy Bowler, who was Vice President, Clinical Development, is promoted to Chief Medical Officer  (posted on January 7 2026).

Create your alert
to follow the executive moves at Volastra Therapeutics.

Volastra Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Volastra Therapeutics

• News - Volastra
• Press Releases - Volastra

Social media about Volastra Therapeutics

• Volastra Therapeutics on Wikipedia, Google News & Yahoo Finance
• Volastra Therapeutics on LinkedIn, X (Twitter) & YouTube